CAS 333745-53-2

LX2343

CAS: 333745-53-2

Fórmula: C₂₂H₁₉ClN₂O₆S

Pureza: %

Cor e Forma: Solid

Peso molecular: 474.9141

Ref: IN-DA01EOA3

LX2343

CAS: 333745-53-2

LX2343

Pureza: ≥98%

Peso molecular: 474.91g/mol

Ref: 54-BUP10097

LX2343

CAS: 333745-53-2

LX2343 inhibits BACE1 (IC50: 11.43 μM) and PI3K non-competitively (IC50: 15.99 μM), and enhances autophagy for Aβ removal.

Fórmula: C₂₂H₁₉ClN₂O₆S

Pureza: 99.45%

Cor e Forma: Solid

Peso molecular: 474.91

Ref: TM-T4398

LX-2343

CAS: 333745-53-2

LX-2343 is a novel small molecule that induces autophagy. It has been shown to potently inhibit the growth of cancer cells in cell-based assays and to promote neuroprotective effects in rats with brain injury. LX-2343 can also reduce the levels of human chorionic gonadotropin (hCG) in blood and decrease hCG production in the brain, which may be an effective therapy for treating tumors caused by hCG-producing cancers such as ovarian cancer. LX-2343 also inhibits the biosynthesis of hCG by blocking the activity of its two major enzymes, chorionic gonadotropin beta-subunit synthase and 3'5'-cyclic adenosine monophosphate (cAMP) kinase type I.

Fórmula: C₂₂H₁₉ClN₂O₆S

Pureza: Min. 95%

Peso molecular: 474.91 g/mol

Ref: 3D-INA74553